Global Cell Line Development Market Report 2024

The cell line development market size has grown rapidly in recent years. It will grow from $7.16 billion in 2023 to $8.21 billion in 2024 at a compound annual growth rate (CAGR) of 14.7%. The growth observed during the historic period can be attributed to several factors, including increased vaccine production, a growing aging population, and an uptick in clinical trials.

The cell line development market size is expected to see rapid growth in the next few years. It will grow to $14.25 billion in 2028 at a compound annual growth rate (CAGR) of 14.8%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing prevalence of cancer and chronic diseases, as well as growing government investments in healthcare. Major trends expected in the forecast period include partnerships, investments, and product innovations.

The anticipated rise in cancer prevalence is poised to drive the growth of cell line development in the foreseeable future. Cancer refers to a group of diseases characterized by the uncontrolled proliferation and spread of abnormal cells within the body. The increase in cancer cases is attributed primarily to factors such as population growth, aging, lifestyle choices, obesity, and genetic predisposition. Cell lines serve as crucial tools for screening potential drugs for their efficacy in treating chronic diseases. Researchers expose these cell lines to various compounds and observe their effects, facilitating the identification of promising drug candidates for further development. For instance, according to the World Health Organization's February 2024 report, the projected number of new cancer cases is expected to reach over 35 million by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Thus, the growing prevalence of cancer serves as a catalyst for the cell line development market.

Key players in the cell line development market are actively pursuing innovative platforms to gain a competitive advantage. These innovative platforms are distinguished by their ability to streamline and optimize the cell line development process, offering speed, efficiency, and enhanced productivity to support the development of biological drugs. For example, in January 2023, Abzena, a UK-based company providing outsourced research, development, and manufacturing services, introduced new platforms named AbZelect and AbZelectPro, designed to accelerate the cell line development (CLD) process for biologic drug programs. These platforms enhance productivity, enabling the production of greater quantities of drug substances per manufacturing run. This heightened efficiency not only expands capacity and reduces costs for customers but also expedites the delivery of critical therapies to patients in need.

In October 2022, Cytiva, a US-based life sciences company, acquired CEVEC Pharmaceuticals for an undisclosed sum. This acquisition bolsters Cytiva's capabilities in biomanufacturing solutions and supports the company's expansion in the genomic medicine sector. CEVEC Pharmaceuticals, headquartered in Germany, specializes in high-performance cell line development and viral vector manufacturing technologies.

Major companies operating in the cell line development market are Thermo Fisher Scientific Inc., Novartis AG, Danaher Corporation, Merck KGaA, GE Health Care, AGC Biologics, Corning Inc., Eurofins Scientific, Lonza Pvt. Ltd., WuXi App tech, Sartorius AG, GenScript Biotech Corporation, FUJIFILM Diosynth Biotechnologies, Promega corporation, KBI Biopharma Inc., Rentschler Biopharma SE, Advanced Instruments LLC, Cyagen, Horizon Discovery Group Plc, Probiogen AG, PromoCell GmbH, Premas Biotech, Imgenex, NAEJA RGM Pharmaceuticals Inc.

North America was the largest region in the cell line development market in 2023. The regions covered in the cell line development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell line development market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Cell line development involves the creation of immortalized cell cultures derived from specific cell types, often originating from a particular organism or tissue. These cell lines are nurtured under controlled laboratory conditions and can be perpetually cultivated and reproduced.

The primary product types associated with cell line development include reagents and media, equipment, accessories, and consumables. Reagents and media encompass essential components utilized in laboratory settings for diverse biological and chemical analyses, experiments, and procedures. These components are sourced from various organisms, including mammalian and non-mammalian, and are utilized to generate different types of cell lines such as recombinant, hybridomas, continuous cell lines, and primary cell lines. Applications for these cell lines span bioproduction, drug discovery, toxicity testing, tissue engineering, and research endeavors.

The cell line development market research report is one of a series of new reports that provides cell line development market statistics, including cell line development industry global market size, regional shares, competitors with a cell line development market share, detailed cell line development market segments, market trends, and opportunities, and any further data you may need to thrive in the cell line development industry. This cell line development research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell line development market consists of sales of primary cell lines, immortalized cell lines, stable cell lines, and clonal cell lines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.